GO:0090673 endothelial cell-matrix adhesion: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090673 endothelial cell-matrix adhesion is defined as the binding of an endothelial cell to the extracellular matrix via adhesion molecules.
• Integrin-dependent adhesion complexes are the central molecular machinery that anchors endothelial cells to matrix ligands and transmits mechanical and biochemical signals.
• Cell-matrix adhesion is dynamically assembled in a hierarchical manner, beginning with nascent adhesions and maturing into focal adhesions and fibrillar adhesions.
• Loss of endothelial adhesion and matrix organization contributes to thoracic aortic dissection, pulmonary hypertension, and tumor cell dissemination.
• Galectin-3, ITGA5, and SMAD4 are representative regulators that modulate endothelial cell-matrix adhesion in health and disease.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of adhesion genes in endothelial cells.
Description
Endothelial cells form the inner lining of blood vessels and must remain firmly attached to the underlying extracellular matrix to maintain vascular barrier function, respond to shear stress, and coordinate angiogenesis. The Gene Ontology term GO:0090673 endothelial cell-matrix adhesion captures the binding of an endothelial cell to the extracellular matrix via adhesion molecules, a process that is essential for vascular homeostasis and is disrupted in multiple human diseases. Researchers studying vascular biology, cancer metastasis, and cardiovascular pathology therefore need a precise understanding of the molecules and mechanisms that execute this adhesion process. Integrin receptors, focal adhesion proteins, and matrix-remodeling enzymes cooperate to build adhesion complexes that are both structural anchors and signaling hubs. Because adhesion is dynamic, it is regulated by extracellular cues such as nitric oxide and hypoxia, and by intracellular signals that control integrin activation and turnover. This article summarizes the authoritative GO definition, the core molecular events, the key genes, the disease links, and the experimental methods used to study endothelial cell-matrix adhesion.
endothelial cell-matrix adhesion At A Glance
| GO ID | GO:0090673 |
|---|---|
| GO term | endothelial cell-matrix adhesion |
| Ontology | biological_process |
| Synonym | none |
| Definition | The binding of an endothelial cell to the extracellular matrix via adhesion molecules. |
| Major function | Anchors endothelial cells to the extracellular matrix and transmits adhesion-dependent signals. |
| Key molecular players | Integrins, focal adhesion proteins, galectin-3, SMAD4, and matrix-remodeling enzymes. |
| Associated diseases | Thoracic aortic dissection, pulmonary hypertension, and cancer metastasis. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, imaging, and proteomics. |
What Is GO:0090673?
GO:0090673 endothelial cell-matrix adhesion is a biological process defined as the binding of an endothelial cell to the extracellular matrix via adhesion molecules. In practice, this means the physical and biochemical interaction between adhesion receptors on the endothelial cell surface, such as integrins, and specific components of the extracellular matrix, including fibronectin, collagen, and laminin. This binding is not a passive event; it nucleates the assembly of adhesion complexes that connect the matrix to the actin cytoskeleton and initiate intracellular signaling.
Why Is endothelial cell-matrix adhesion Important in Cell Biology?
Endothelial cell-matrix adhesion is important because it determines whether endothelial cells remain quiescent and barrier-protective or become activated and dysfunctional. Integrin-dependent adhesion controls vascular permeability, leukocyte extravasation, angiogenesis, and the response to hemodynamic forces. When adhesion is weakened, endothelial cells detach, matrix organization is impaired, and diseases such as thoracic aortic dissection and pulmonary hypertension can develop. Conversely, tumor cells can exploit endothelial retraction and matrix exposure to adhere and disseminate, linking this process directly to cancer progression.
• Maintains vascular barrier integrity by anchoring endothelial cells to the extracellular matrix.
• Transmits mechanical and biochemical signals that regulate endothelial survival, proliferation, and migration.
• Controls angiogenesis and vascular remodeling during development and tissue repair.
• Disruption contributes to thoracic aortic dissection through focal adhesion destabilization.
• Impaired adhesion and matrix organization promote pulmonary hypertension.
• Nitric oxide and hypoxia modulate endothelial progenitor cell adhesion via ITGA5 promoter demethylation.
• Galectin-3-integrin interactions mediate adhesion in endothelial cells and mesenchymal stem cells.
• Endothelial retraction exposes subendothelial matrix and enhances tumor cell adhesion.
• Serves as a target for therapeutic strategies aimed at stabilizing or disrupting vascular adhesion.
• Provides a mechanistic entry point for CRISPR-based functional genomics in vascular biology.
What Happens During endothelial cell-matrix adhesion?
Integrin activation and ligand binding
In simple terms: Integrins on the endothelial cell surface switch to an active shape so they can grab matrix proteins.
Endothelial cell-matrix adhesion begins when integrin heterodimers on the endothelial surface become activated and bind extracellular matrix ligands such as fibronectin, collagen, and laminin. This binding is the defining event of GO:0090673 and is required for subsequent adhesion complex assembly. Integrin-dependent adhesion is central to endothelial health, and its dysregulation is linked to vascular disease.
Hierarchical assembly of adhesion complexes
In simple terms: Adhesion structures are built in stages, from small initial contacts to large mature anchors.
After ligand binding, adhesion complexes assemble in a hierarchical manner, progressing from nascent adhesions to focal adhesions and then to fibrillar adhesions. This stepwise maturation allows the endothelial cell to strengthen its attachment and to organize the actin cytoskeleton. The composition of these complexes changes as they mature, enabling distinct signaling outputs.
Cytoskeletal coupling and mechanotransduction
In simple terms: The adhesion anchors are connected to the cell's internal skeleton, allowing the cell to feel and respond to forces.
Mature adhesion complexes link matrix-bound integrins to the actin cytoskeleton, creating a mechanical connection that transmits forces across the cell membrane. This mechanotransduction influences endothelial cell shape, migration, and survival. Disruption of this coupling can destabilize focal adhesions and compromise vascular integrity.
Regulation by nitric oxide and hypoxia
In simple terms: Chemical signals such as nitric oxide and low oxygen can strengthen or weaken adhesion.
Nitric oxide promotes cell-matrix adhesion of endothelial progenitor cells under hypoxia via ITGA5 CpG promoter demethylation, linking environmental cues to epigenetic control of adhesion. This regulation shows that endothelial cell-matrix adhesion is not constitutive but responsive to the metabolic and oxygen status of the cell.
Matrix organization and remodeling
In simple terms: Endothelial cells not only stick to the matrix but also help organize and reshape it.
Endothelial cells contribute to extracellular matrix organization, and loss of SMAD4 impairs both cell adhesion and matrix organization in the context of pulmonary hypertension. This feedback between adhesion and matrix remodeling is essential for maintaining a stable vascular wall.
Key Genes Involved in GO:0090673 endothelial cell-matrix adhesion
The following genes and proteins are experimentally implicated in endothelial cell-matrix adhesion and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ITGB1 | Integrin beta-1 subunit that binds matrix ligands | Core mediator of endothelial adhesion and signaling |
| ITGA5 | Integrin alpha-5 subunit for fibronectin binding | Regulated by nitric oxide and hypoxia via promoter demethylation |
| ITGAV | Integrin alpha-V subunit in matrix adhesion | Integrin-dependent endothelial adhesion in health and disease |
| LGALS3 | Galectin-3 that interacts with integrins | Mediates cell-matrix adhesion in endothelial cells |
| SMAD4 | TGF-beta signaling mediator | Deficiency impairs endothelial adhesion and matrix organization |
| CAPN2 | Calpain-2 protease that cleaves focal adhesion proteins | Mediates focal adhesion disruption in thoracic aortic dissection |
| PTK2 | Focal adhesion kinase (FAK) signaling | Central to adhesion complex signaling |
| VCL | Vinculin that links integrins to actin | Structural component of focal adhesions |
| TLN1 | Talin that activates integrins | Required for adhesion complex assembly |
| PXN | Paxillin scaffold in focal adhesions | Hierarchical assembly of adhesion complexes |
| ACTN1 | Alpha-actinin actin crosslinker | Cytoskeletal coupling at adhesion sites |
| FN1 | Fibronectin matrix ligand | Extracellular ligand for integrin binding |
| COL1A1 | Collagen matrix ligand | Extracellular matrix component bound by integrins |
| LAMA1 | Laminin matrix ligand | Basement membrane ligand for endothelial adhesion |
| ZYX | Zyxin at adhesion plaques | Adhesion complex composition and dynamics |
| FERMT2 | Kindlin-2 integrin activator | Integrin activation in endothelial adhesion |
| ARHGAP24 | Regulator of Rho GTPase and adhesion turnover | Adhesion dynamics in endothelial cells |
How Is endothelial cell-matrix adhesion Regulated?
Endothelial cell-matrix adhesion is regulated at multiple levels. Integrin activation and clustering are controlled by intracellular proteins such as talin and kindlin, and adhesion turnover is influenced by Rho GTPase signaling. Nitric oxide promotes adhesion of endothelial progenitor cells under hypoxia by demethylating the ITGA5 CpG promoter, providing an epigenetic layer of regulation. SMAD4-dependent signaling is required for normal endothelial adhesion and extracellular matrix organization, and its loss leads to pulmonary hypertension. Calpain-2-mediated proteolysis can disrupt focal adhesions, showing that adhesion is also subject to protease-dependent negative regulation.
endothelial cell-matrix adhesion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CAPN2 | Thoracic aortic dissection | Knockout or point-mutation endothelial cell model |
| SMAD4 | Pulmonary hypertension | Endothelial-specific knockout |
| ITGA5 | Hypoxia-related adhesion | Promoter methylation reporter and knockout |
| LGALS3 | Adhesion in endothelial cells and MSCs | Knockout and overexpression |
| ITGB1 | Vascular adhesion in health and disease | Conditional knockout and knock-in |
Thoracic aortic dissection
Calpain-2-mediated disruption of endothelial focal adhesions contributes to thoracic aortic dissection, linking loss of cell-matrix adhesion to structural failure of the aortic wall. This highlights adhesion stability as a determinant of vascular integrity.
Pulmonary hypertension
Endothelial SMAD4 deficiency promotes pulmonary hypertension by impairing cell adhesion and extracellular matrix organization. This demonstrates that adhesion defects can drive chronic vascular remodeling.
Cancer metastasis
Enhanced tumor cell adhesion to the subendothelial matrix can result from 12(S)-HETE-induced endothelial cell retraction, exposing matrix proteins that tumor cells bind. Vascular cell-matrix adhesion is therefore relevant to both development and cancer.
Vascular development and repair
Vascular cell-matrix adhesion is essential during development and in cancer-associated angiogenesis, where endothelial cells must dynamically attach and detach from the matrix. Integrin-dependent adhesion in endothelial health and disease is a broad theme in vascular biology.
From endothelial cell-matrix adhesion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the gene required for endothelial adhesion? | CRISPR knockout in endothelial cells |
| Does a specific point mutation alter integrin activation? | Point-mutation knock-in |
| Does a tag affect adhesion complex localization? | Tagged knock-in |
| Does overexpression strengthen adhesion? | Overexpression cell model |
| Which matrix ligand is preferred? | Knockout with matrix-specific adhesion assays |
| Does epigenetic regulation control ITGA5? | Promoter methylation and knockout model |
How to Study the endothelial cell-matrix adhesion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Adhesion assay | Binding of cells to matrix proteins | Quantify endothelial cell-matrix adhesion |
| Immunofluorescence | Localization of focal adhesion proteins | Visualize adhesion complex assembly |
| Proteomics | Protein composition of adhesion complexes | Identify maturation-dependent changes |
| CRISPR knockout | Loss-of-function effect on adhesion | Test gene requirement |
| Point mutation | Effect of specific amino acid change | Test integrin activation mutants |
| Knock-in tagging | Protein localization and dynamics | Track adhesion proteins in live cells |
| Overexpression | Gain-of-function effect on adhesion | Test galectin-3 and integrins |
| Promoter methylation assay | Epigenetic regulation of ITGA5 | Study hypoxia and nitric oxide effects |
Adhesion assays
Adhesion assays measure the ability of endothelial cells to bind specific matrix proteins such as fibronectin, collagen, or laminin, and are used to quantify the functional output of GO:0090673.
Imaging of adhesion complexes
Fluorescence microscopy of focal adhesion proteins such as vinculin, paxillin, and talin reveals the hierarchical assembly and maturation of adhesion complexes.
Proteomics of adhesion complexes
Proteomic analysis of isolated adhesion complexes identifies their changing composition during maturation and in disease states.
Genetic and epigenetic perturbation
CRISPR knockout, point mutation, and promoter methylation analysis can test causal roles of genes such as ITGA5, SMAD4, and LGALS3 in endothelial adhesion.
How CRISPR Can Be Used to Study GO:0090673 endothelial cell-matrix adhesion
Knockout
CRISPR knockout of genes such as ITGB1, SMAD4, or LGALS3 in endothelial cells can determine whether they are required for cell-matrix adhesion and matrix organization.
Point Mutation
Point mutations can be introduced into integrin genes to test the effect of specific residues on activation and ligand binding, as integrin-dependent adhesion is sensitive to conformational changes.
Knock-in
Knock-in of fluorescent or affinity tags into focal adhesion genes such as VCL or PXN allows real-time tracking of adhesion complex assembly and maturation.
Overexpression
Overexpression of galectin-3 or integrin subunits can test whether increased levels strengthen endothelial cell-matrix adhesion and downstream signaling.
How EDITGENE Supports endothelial cell-matrix adhesion Research
Researchers studying endothelial cell-matrix adhesion-related genes often need to determine whether a candidate gene is causally involved in adhesion, matrix organization, or vascular disease. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbation of adhesion genes in endothelial cells.
Contact EDITGENE today to design your custom CRISPR model for endothelial cell-matrix adhesion research.
Frequently Asked Questions About endothelial cell-matrix adhesion
What is GO:0090673 endothelial cell-matrix adhesion?
GO:0090673 is a biological process defined as the binding of an endothelial cell to the extracellular matrix via adhesion molecules.
What genes are involved in endothelial cell-matrix adhesion?
Key genes include ITGB1, ITGA5, LGALS3, SMAD4, CAPN2, PTK2, VCL, TLN1, and PXN.
Why is endothelial cell-matrix adhesion important?
It anchors endothelial cells to the matrix, maintains vascular barrier function, and transmits signals that regulate survival and migration.
How is endothelial cell-matrix adhesion regulated?
It is regulated by integrin activation, Rho GTPase signaling, nitric oxide, hypoxia, SMAD4 signaling, and calpain-2-mediated proteolysis.
What diseases are linked to endothelial cell-matrix adhesion?
Thoracic aortic dissection, pulmonary hypertension, and cancer metastasis are linked to defects in this process.
How do researchers study endothelial cell-matrix adhesion?
Common methods include adhesion assays, immunofluorescence, proteomics, and CRISPR-based genetic perturbation.
What is the role of integrins in endothelial cell-matrix adhesion?
Integrins are the primary adhesion receptors that bind matrix ligands and nucleate adhesion complex assembly.
Can CRISPR be used to study endothelial cell-matrix adhesion?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test causal roles of adhesion genes.
What is the role of galectin-3 in endothelial adhesion?
Galectin-3 interacts with integrins to mediate cell-matrix adhesion in endothelial cells and mesenchymal stem cells.
How does SMAD4 affect endothelial adhesion?
Endothelial SMAD4 deficiency impairs cell adhesion and extracellular matrix organization, promoting pulmonary hypertension.
Conclusion
GO:0090673 endothelial cell-matrix adhesion is a fundamental biological process that anchors endothelial cells to the extracellular matrix and coordinates vascular signaling. Integrin-dependent adhesion complexes, regulated by proteins such as SMAD4, galectin-3, and calpain-2, are central to vascular health, and their disruption contributes to thoracic aortic dissection, pulmonary hypertension, and cancer metastasis. CRISPR-based cell models provide a powerful approach to dissect the causal roles of adhesion genes and to identify new therapeutic targets.
References
- 1. Aman J et al.. 2023. Integrin-Dependent Cell-Matrix Adhesion in Endothelial Health and Disease.. Circ Res 132(3):355-378 PMID: 36730379
- 2. Teng X et al.. 2025. Calpain-2-Mediated Endothelial Focal Adhesion Disruption in Thoracic Aortic Dissection.. Adv Sci (Weinh) 12(25):e2501112 PMID: 40171827
- 3. Arapatzi C et al.. 2022. Vascular cell-matrix adhesion in development and cancer.. Int J Dev Biol 66(1-2-3):103-113 PMID: 34881799
- 4. Lv W et al.. 2025. Endothelial SMAD4 Deficiency Promotes Pulmonary Hypertension by Impairing Cell Adhesion and Extracellular Matrix Organization.. Hypertension 82(7):1175-1191 PMID: 40211949
- 5. Behera J et al.. 2023. Nitric oxide promotes cell-matrix adhesion of endothelial progenitor cells under hypoxia condition via ITGA5 CpG promoter demethylation.. Biochem Biophys Res Commun 644:162-170 PMID: 36669384
- 6. Honn KV et al.. 1989. Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12(S)-HETE-induced endothelial cell retraction.. FASEB J 3(11):2285-93 PMID: 2673900
- 7. Zaidel-Bar R et al.. 2004. Hierarchical assembly of cell-matrix adhesion complexes.. Biochem Soc Trans 32(Pt3):416-20 PMID: 15157150
- 8. Sedlář A et al.. 2021. Interaction between Galectin-3 and Integrins Mediates Cell-Matrix Adhesion in Endothelial Cells and Mesenchymal Stem Cells.. Int J Mol Sci 22(10) PMID: 34067978
